[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BioCentury Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::227778014.png) BioCentury [@BioCentury](/creator/twitter/BioCentury) on x 16.3K followers
Created: 2025-07-18 21:30:12 UTC

Capital flows continue in Asia. Ascentage Pharma raises $192M in Hong Kong placement while Korea-based Illimis raises $XX million in a series B round: BioCentury's latest Finance Report

![](https://pbs.twimg.com/card_img/1946321636673662976/GQGyit_p?format=jpg&name=800x419)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946321633376944468/c:line.svg)

**Related Topics**
[finance](/topic/finance)
[seed funding](/topic/seed-funding)
[kong](/topic/kong)
[hong kong](/topic/hong-kong)
[$192m](/topic/$192m)
[asia](/topic/asia)

[Post Link](https://x.com/BioCentury/status/1946321633376944468)